Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.

Conditions:   Hypertension;   Hypertension,Essential Interventions:   Drug: fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg;   Drug: Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg) Sponsor:   Brainfarma Industria Química e Farmacêutica S/A Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials